Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hello Device Tax, We Hardly Missed You: Companies Seek IRS Action To Stall Tax

Executive Summary

With congressional options exhausted for 2017, industry hopes for IRS relief from the device-tax reality, either with a temporary waiver of deposit penalties or some broader tax-enforcement delay.

You may also be interested in...



With Legislation In Balance, IRS Gives Temporary Relief From Device Tax Penalty

The Internal Revenue Services will hold off penalizing medical device-makers for late payments of the device tax for the first three quarters of the year, after lobbying from industry and lawmakers.

Medtech's Unfinished Business For Congress In 2018: What's Ahead

US Congress successfully pushed through a user-fee bill in 2017 to help smooth the regulatory path at FDA for medical devices and other products, but other efforts, including several industry priorities, remain undone. On top on the list, of course, is the effort to repeal the device excise tax. But legislation is also on the table to address diagnostics regulation, telehealth reimbursement, and medtech cybersecurity vulnerability, among other issues. Here is a look at the medtech landscape in Congress in 2018.

Problem Solved? Health-Care Bill From US House Caucus Aims To Repeal Device Tax By Year's End

Time's running out for Congress to repeal the 2.3% medical device excise tax before its suspension ends on Dec. 31. But a new health-care bill introduced yesterday by the House Problem Solvers Caucus could kill the tax by then.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel